002603 以岭药业
已收盘 11-26 15:00:00
资讯
新帖
简况
以岭药业：携创新中药抗衰成果参加千人抗衰论坛，业内评价其或迎业绩突破
证券之星 · 11-21
以岭药业：携创新中药抗衰成果参加千人抗衰论坛，业内评价其或迎业绩突破
以岭药业荣获“2024中医药传承与创新最佳实践案例”称号
证券之星 · 11-19
以岭药业荣获“2024中医药传承与创新最佳实践案例”称号
以岭药业荣获证券之星资本力量2024年度最具社会责任上市公司奖
证券之星 · 11-14
以岭药业荣获证券之星资本力量2024年度最具社会责任上市公司奖
以岭药业板蓝根、黄芪种植基地通过河北省药品监督管理局中药材GAP延伸检查
证券之星 · 11-08
以岭药业板蓝根、黄芪种植基地通过河北省药品监督管理局中药材GAP延伸检查
第二届中医药文化国际传播案例揭晓！以岭药业榜上有名
证券之星 · 11-06
第二届中医药文化国际传播案例揭晓！以岭药业榜上有名
以岭药业(002603)：多重因素短期扰动 学术创新赋能发展
证券之星 · 11-05
以岭药业(002603)：多重因素短期扰动 学术创新赋能发展
络病理论原创是以岭药业高质量发展的“根”与“魂”
证券之星 · 11-01
络病理论原创是以岭药业高质量发展的“根”与“魂”
以岭药业：10月29日召开业绩说明会，华创证券、申万宏源等多家机构参与
证券之星 · 10-31
以岭药业：10月29日召开业绩说明会，华创证券、申万宏源等多家机构参与
以岭药业通过知识产权合规管理体系新国标认证
证券之星 · 10-30
以岭药业通过知识产权合规管理体系新国标认证
公司零距离·新经济 新动能|以岭药业：加速中医药国际化进程
证券之星 · 10-30
公司零距离·新经济 新动能|以岭药业：加速中医药国际化进程
以岭药业三季报解读：呼吸板块拐点临近，大健康和配方颗粒高速增长
证券之星 · 10-29
以岭药业三季报解读：呼吸板块拐点临近，大健康和配方颗粒高速增长
以岭药业(002603.SZ)发布前三季度业绩，净利润5.55亿元，同比下降68.46%
智通财经 · 10-28
以岭药业(002603.SZ)发布前三季度业绩，净利润5.55亿元，同比下降68.46%
以岭药业：传承与创新并举，引领中医药现代化新征程
证券之星 · 10-28
以岭药业：传承与创新并举，引领中医药现代化新征程
海外专家团访问北京以岭药业 探讨中医药临床应用前景
证券之星 · 10-28
海外专家团访问北京以岭药业 探讨中医药临床应用前景
以岭药业向太仆寺旗红十字会捐赠价值300万元连花系列产品
证券之星 · 10-21
以岭药业向太仆寺旗红十字会捐赠价值300万元连花系列产品
以岭药业(002603.SZ)化药创新药“G201-Na胶囊”药物临床试验申请获得受理
智通财经 · 10-17
以岭药业(002603.SZ)化药创新药“G201-Na胶囊”药物临床试验申请获得受理
以岭药业：通心络胶囊、参松养心胶囊和芪苈强心胶囊的市场份额升至16.61%
证券之星 · 10-17
以岭药业：通心络胶囊、参松养心胶囊和芪苈强心胶囊的市场份额升至16.61%
暖心服务为职工，助力生产促发展 以岭药业工会获“全国模范职工之家”荣誉称号
证券之星 · 10-17
暖心服务为职工，助力生产促发展 以岭药业工会获“全国模范职工之家”荣誉称号
10月9日以岭药业跌8.53%，汇添富中证中药ETF基金重仓该股
证券之星 · 10-09
10月9日以岭药业跌8.53%，汇添富中证中药ETF基金重仓该股
以岭药业(002603.SZ)：中药新药“连花御屏颗粒”药物临床试验申请获得受理
智通财经 · 10-08
以岭药业(002603.SZ)：中药新药“连花御屏颗粒”药物临床试验申请获得受理
暂无数据
公司概况
公司名称：
石家庄以岭药业股份有限公司
所属行业：
医药制造业
上市日期：
2011-07-28
主营业务：
石家庄以岭药业股份有限公司是一家主要致力于专利创新中药的研发、生产和销售。主要产品包括通心络胶囊、参松养心胶囊、连花清瘟胶囊、芪苈强心胶囊等。公司拥有通过GMP认证的胶囊、片剂、颗粒剂、针剂生产线,以及通过欧盟认证的化学药制剂车间。
发行价格：
34.56
{"stockData":{"symbol":"002603","market":"SZ","secType":"STK","nameCN":"以岭药业","latestPrice":16.97,"timestamp":1732604634000,"preClose":16.91,"halted":0,"volume":10374830,"delay":0,"floatShares":1376000000,"shares":1671000000,"eps":0.0889,"marketStatus":"已收盘","marketStatusCode":5,"change":0.06,"latestTime":"11-26 15:00:00","open":16.92,"high":17.2,"low":16.84,"amount":177000000,"amplitude":0.0213,"askPrice":16.98,"askSize":262,"bidPrice":16.97,"bidSize":153,"shortable":0,"etf":0,"ttmEps":0.0889,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732671000000},"adr":0,"adjPreClose":16.91,"symbolType":"stock","openAndCloseTimeList":[[1732584600000,1732591800000],[1732597200000,1732604400000]],"highLimit":18.6,"lowLimit":15.22,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1670705376,"pbRate":2.46,"roa":"--","roe":"4.8%","epsLYR":0.8095,"committee":0.081081,"marketValue":28352000000,"floatMarketCap":23356000000,"peRate":190.888639,"changeRate":0.0035,"turnoverRate":0.0075,"status":0},"requestUrl":"/m/hq/s/002603/tweets","defaultTab":"tweets","newsList":[{"id":"2485452331","title":"以岭药业：携创新中药抗衰成果参加千人抗衰论坛，业内评价其或迎业绩突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2485452331","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485452331?lang=zh_cn&edition=full","pubTime":"2024-11-21 17:04","pubTimestamp":1732179889,"startTime":"0","endTime":"0","summary":"月初，在一场规模逾千人的衰老干预论坛上，来自中外的抗衰极客和爱好者们，围着以岭药业的展台不断向工作人员提问。据在场科研人员介绍，八子补肾胶囊干预衰老主要基于“气络学说精气神理论”指导，具有补肾填精、燮理阴阳、温扶元气、充养形神之功。近两年，在抗衰领域一鸣惊人的中药抗衰成果“八子补肾胶囊”，不但为全球抗衰技术发展注入了新活力，也给国内5亿50岁以上的中老年，带来了由“养老”到“乐老”的希望。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2024112100027012.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0239","BK0042","002603","BK0046","BK0188"],"gpt_icon":0},{"id":"2484953456","title":"以岭药业荣获“2024中医药传承与创新最佳实践案例”称号","url":"https://stock-news.laohu8.com/highlight/detail?id=2484953456","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484953456?lang=zh_cn&edition=full","pubTime":"2024-11-19 09:33","pubTimestamp":1731980003,"startTime":"0","endTime":"0","summary":"近日，由中国医药企业管理协会、中国医药生物技术协会等主办，E药经理人等承办的2024“第十六届中国医药企业家科学家投资家大会”在成都举行。经组委会评定认为，以岭药业在中医药现代化创新方面表现卓越，为行业树立了良好榜样，特授予“2024中医药传承与创新最佳实践案例”称号。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2024111900009405.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0046","BK0042","002603","BK0239","BK0188"],"gpt_icon":0},{"id":"2483896579","title":"以岭药业荣获证券之星资本力量2024年度最具社会责任上市公司奖","url":"https://stock-news.laohu8.com/highlight/detail?id=2483896579","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483896579?lang=zh_cn&edition=full","pubTime":"2024-11-14 09:41","pubTimestamp":1731548507,"startTime":"0","endTime":"0","summary":"在本届资本力量活动中，以岭药业荣获最具社会责任上市公司奖。以岭药业，作为国家重点高新技术企业，始终坚持“继承创新、造福人类”的企业宗旨，在推动中医药现代化、产业化和国际化进程中发挥了重要作用。在经营中，以岭药业积极采用先进技术与设备，加强废弃物回收利用，营造绿色环保氛围，助力实现“双碳”目标。以岭药业的社会责任实践不仅体现在对中药材产业的深耕，还体现在对环境保护的承诺。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.stockstar.com/SS2024111400009955.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","161912","BK0046","BK0042","002603","161027","BK0239","BK0188"],"gpt_icon":0},{"id":"2481011817","title":"以岭药业板蓝根、黄芪种植基地通过河北省药品监督管理局中药材GAP延伸检查","url":"https://stock-news.laohu8.com/highlight/detail?id=2481011817","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481011817?lang=zh_cn&edition=full","pubTime":"2024-11-08 13:02","pubTimestamp":1731042155,"startTime":"0","endTime":"0","summary":"11月6日，河北省药品监督管理局发布《河北省药品监督管理局中药材GAP延伸检查结果公告》称，河北省药品监督管理局组织对石家庄以岭药业股份有限公司板蓝根、黄芪种植基地进行了《中药材生产质量管理规范》延伸检查，经综合评定符合GAP要求。据了解，今年6月28日，以岭药业的连翘种植基地也通过了河北省药品监督管理局GAP延伸检查，该基地成为河北省首个通过中药材GAP延伸检查基地。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2024110800018320.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","002603","BK0239","BK0188","BK0046","BK0097"],"gpt_icon":0},{"id":"2481695040","title":"第二届中医药文化国际传播案例揭晓！以岭药业榜上有名","url":"https://stock-news.laohu8.com/highlight/detail?id=2481695040","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481695040?lang=zh_cn&edition=full","pubTime":"2024-11-06 09:32","pubTimestamp":1730856747,"startTime":"0","endTime":"0","summary":"日前，2024中医药文化国际传播交流会暨彝医药大健康产业发展宣介会在云南楚雄举行。会议期间，公布了第二届中医药文化国际传播案例入围名单，《以岭药业“中药现代化”之路：讲好出海故事，国际化进程独占鳌头》案例榜上有名。除以岭药业外，入围单位还包括了世界针灸学会联合会、北京中医药大学国家中医国际传播中心、中共兰州市委宣传部和甘肃中医药大学、楚雄彝族自治州中医医院等。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2024110600009638.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0097","002603","BK0042","BK0188","BK0046"],"gpt_icon":0},{"id":"2481152142","title":"以岭药业(002603)：多重因素短期扰动 学术创新赋能发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2481152142","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481152142?lang=zh_cn&edition=full","pubTime":"2024-11-05 17:09","pubTimestamp":1730797750,"startTime":"0","endTime":"0","summary":"24Q3 单季度实现营收17.61 亿，同比-1.30%；归母净利润0.24亿，同比-84.07%；扣非归母净利润0.03亿，同比-97. 41%。不断推进新产品研发，看好创新持续赋能发展。公司目前已获临床批件品种涉及风湿免疫系统、消化系统、五官科及儿科等疾病， 看好后续创新进展持续赋能公司长期发展。毛利率短期承压。24Q1-3 公司综合毛利率为53.39%，同比-7.62 pct；24Q3 单季度综合毛利率为53. 46% ，同比-4.8 pct。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2024110500029756.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002603","BK0188","BK0042","BK0097","BK0046","BK0239"],"gpt_icon":0},{"id":"2480365011","title":"络病理论原创是以岭药业高质量发展的“根”与“魂”","url":"https://stock-news.laohu8.com/highlight/detail?id=2480365011","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480365011?lang=zh_cn&edition=full","pubTime":"2024-11-01 09:38","pubTimestamp":1730425119,"startTime":"0","endTime":"0","summary":"络病理论是中医药传承创新发展的典范经过数十年探索研究，以岭药业首次系统构建络病理论体系，出版《络病学》《脉络论》《气络论》专著，被称为络病发展史上第四个里程碑。下一步，以岭药业将持续传承创新，着力抓好科研攻关和成果转化，为企业健康持续发展提供不竭动力，推动产业集群高质量发展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2024110100011810.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0188","BK0239","BK0046","BK0097","002603"],"gpt_icon":0},{"id":"2479471036","title":"以岭药业：10月29日召开业绩说明会，华创证券、申万宏源等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2479471036","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479471036?lang=zh_cn&edition=full","pubTime":"2024-10-31 11:07","pubTimestamp":1730344039,"startTime":"0","endTime":"0","summary":"证券之星消息，2024年10月30日以岭药业发布公告称公司于2024年10月29日召开业绩说明会，华创证券、申万宏源、中泰证券、招商证券、德邦证券、东北证券、中邮证券、开源证券、华西证券、西部证券、投资机构、国盛证券、海通证券、中信建投证券、中金公司、兴业证券、华泰证券、华福证券、浙商证券参与。以岭药业连续 20 年召开国际络病学大会，与多家国际医学科研机构开展合作，","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103100019234.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","BK0276","BK0028","BK0188","000166","BK0239","BK0183","BK0046","BK0012","BK0042","BK1147","06806","002603","BK0097","BK1564"],"gpt_icon":0},{"id":"2479721637","title":"以岭药业通过知识产权合规管理体系新国标认证","url":"https://stock-news.laohu8.com/highlight/detail?id=2479721637","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479721637?lang=zh_cn&edition=full","pubTime":"2024-10-30 11:02","pubTimestamp":1730257329,"startTime":"0","endTime":"0","summary":"近日，石家庄以岭药业股份有限公司通过《企业知识产权合规管理体系要求》国家标准认证，并获得知识产权合规管理体系认证证书。截至2024年6月30日，以岭药业有效专利达 860 项。以岭药业相关负责人表示，公司的知识产权管理工作得到审核专家的高度评价，零缺陷、一次性通过认证，这也标志着以岭药业知识产权工作规范化、标准化水平再上一个新台阶。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2024103000016772.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","BK0188","002603","BK0042","BK0097"],"gpt_icon":0},{"id":"2479292237","title":"公司零距离·新经济 新动能|以岭药业：加速中医药国际化进程","url":"https://stock-news.laohu8.com/highlight/detail?id=2479292237","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479292237?lang=zh_cn&edition=full","pubTime":"2024-10-30 09:44","pubTimestamp":1730252694,"startTime":"0","endTime":"0","summary":"以岭药业作为率先推动中医药国际化的企业，通过不断创新和努力，逐步打破了障碍，为中医药“出海”开辟了新路径。据了解，截至目前，以岭药业的创新专利中药已经进入全球50多个国家和地区，涵盖心脑血管疾病、呼吸系统疾病、糖尿病等多个领域。以岭药业将继续坚持创新驱动发展战略，在理论创新和科技创新的双轮驱动下，推动中医药的产业化、现代化和国际化进程。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2024103000011961.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0042","BK0188","002603","BK0239","BK0046"],"gpt_icon":0},{"id":"2479475594","title":"以岭药业三季报解读：呼吸板块拐点临近，大健康和配方颗粒高速增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2479475594","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479475594?lang=zh_cn&edition=full","pubTime":"2024-10-29 17:45","pubTimestamp":1730195105,"startTime":"0","endTime":"0","summary":"10月28日晚间，以岭药业发布了2024年三季报。以岭药业主要经营板块仍然稳健，除呼吸系统用药板块仍在去库存周期外，心脑血管用药总体稳定，配方颗粒业务、大健康板块有所突破，成为新的增长点。呼吸板块拐点临近呼吸系统类用药是以岭药业两大基本盘之一。不过，今年以岭药业的大健康板块出现了新的亮点，旗下两款功能性饮料怡梦和津力旺增长较快。据悉，大健康和配方颗粒业务收入目前均已过亿，且仍在高速增长中。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2024102900034008.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002603","BK0239","BK0042","BK0188","BK0097","BK0046"],"gpt_icon":0},{"id":"2478488628","title":"以岭药业(002603.SZ)发布前三季度业绩，净利润5.55亿元，同比下降68.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478488628","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478488628?lang=zh_cn&edition=full","pubTime":"2024-10-28 20:57","pubTimestamp":1730120239,"startTime":"0","endTime":"0","summary":"智通财经APP讯，以岭药业(002603.SZ)发布2024年三季度报告，前三季度，公司实现营业收入63.65亿元，同比下降25.76%。归属于上市公司股东的净利润5.55亿元，同比下降68.46%。归属于上市公司股东的扣除非经常性损益的净利润5.07亿元，同比下降69.07%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1201715.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002603"],"gpt_icon":0},{"id":"2478108750","title":"以岭药业：传承与创新并举，引领中医药现代化新征程","url":"https://stock-news.laohu8.com/highlight/detail?id=2478108750","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478108750?lang=zh_cn&edition=full","pubTime":"2024-10-28 18:35","pubTimestamp":1730111735,"startTime":"0","endTime":"0","summary":"多个品种在国外的注册和上市，正是以岭药业在海外传播中医药文化、推动中医药国际化的具体实践。总结展望未来，以岭药业将继续坚持“传承创新”的理念，通过不断的科研创新和产业布局，实现中医药的现代化和国际化。同时，以岭药业也将继续拓展国内外市场，通过与国际医药企业的合作，将中药推向世界。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2024102800025970.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0046","BK0239","BK0097","002603","BK0188"],"gpt_icon":0},{"id":"2478108614","title":"海外专家团访问北京以岭药业 探讨中医药临床应用前景","url":"https://stock-news.laohu8.com/highlight/detail?id=2478108614","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478108614?lang=zh_cn&edition=full","pubTime":"2024-10-28 18:30","pubTimestamp":1730111403,"startTime":"0","endTime":"0","summary":"北京以岭药业有限公司近日迎来了来自约旦、亚美尼亚、津巴布韦、巴拿马、坦桑尼亚、埃塞俄比亚和斯里兰卡等国的医疗领域专家一行。作为“中药在西医临床上的应用技术研修班”的成员，专家团此次访问北京以岭药业，旨在探讨中医药在医疗体系中的临床应用前景。访问期间，专家团首先参观了北京以岭药业展厅，全面了解了以岭药业在中医药理论创新、成果转化和产业发展方面所取得的突破。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2024102800025906.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002603","BK0188","BK0042","BK0097","BK0046","BK0239"],"gpt_icon":0},{"id":"2477834283","title":"以岭药业向太仆寺旗红十字会捐赠价值300万元连花系列产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2477834283","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477834283?lang=zh_cn&edition=full","pubTime":"2024-10-21 17:49","pubTimestamp":1729504146,"startTime":"0","endTime":"0","summary":"近日，以岭药业向太仆寺旗红十字会捐赠了价值300万元的物资。以岭药业张晓军代表公司向太仆寺旗捐赠300万元连花系列产品。在捐赠现场，以岭药业张晓军代表公司介绍了此次捐赠的相关情况。同时，以岭药业与中国红十字会、中华慈善总会、中国农村卫生协会等组织合作多年来，开展多项慈善公益活动，助力乡村医疗事业发展；重大自然灾害后，积极捐款捐物，助力受灾群众恢复生产生活秩序，早日重建家园。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2024102100023729.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","002603","BK0239","BK0188","BK0046","BK0097"],"gpt_icon":0},{"id":"2476314238","title":"以岭药业(002603.SZ)化药创新药“G201-Na胶囊”药物临床试验申请获得受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2476314238","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476314238?lang=zh_cn&edition=full","pubTime":"2024-10-17 19:44","pubTimestamp":1729165472,"startTime":"0","endTime":"0","summary":"智通财经APP讯，以岭药业(002603.SZ)发布公告，公司于2024年10月17日收到国家药品监督管理局核准签发的化药创新药“G201-Na胶囊”药物临床试验申请《受理通知书》。G201-Na胶囊项目是公司自主研发、具有独立知识产权的1类化学新药。本品为小分子促性腺激素释放激素(GnRH)受体拮抗剂。可以阻断内源性GnRH与GnRH受体的结合，抑制促黄体生成素和卵泡刺激素等促性腺激素的合成和释放，降低睾酮和雌二醇等性激素水平，维持正常的生殖系统功能。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1195552.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0042","159992","BK1141","BK0188","06978","BK0239","BK0046","BK0097","BK1161","BK1583","03347","BK1574","BK1576","002603"],"gpt_icon":0},{"id":"2476136367","title":"以岭药业：通心络胶囊、参松养心胶囊和芪苈强心胶囊的市场份额升至16.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476136367","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476136367?lang=zh_cn&edition=full","pubTime":"2024-10-17 10:16","pubTimestamp":1729131400,"startTime":"0","endTime":"0","summary":"近日，以岭药业举办2024年半年报集体业绩说明会。会上，有投资者询问，苯胺洛芬何时正式上市。对此，以岭药业董事、董秘吴瑞回复，苯胺洛芬申报NDA已获受理。针剂和口服出现结构性变化，口服制剂市场份额由2015年的34.76%增至2023年的60.84%，持续占据领先地位。本公司通心络胶囊、参松养心胶囊和芪苈强心胶囊三大创新专利中药市场份额由2015年的13.64%提升至2023年的16.61%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2024101700010745.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","002603","BK0097","BK0046","BK0042","BK0239"],"gpt_icon":0},{"id":"2476136366","title":"暖心服务为职工，助力生产促发展 以岭药业工会获“全国模范职工之家”荣誉称号","url":"https://stock-news.laohu8.com/highlight/detail?id=2476136366","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476136366?lang=zh_cn&edition=full","pubTime":"2024-10-17 10:11","pubTimestamp":1729131092,"startTime":"0","endTime":"0","summary":"近日，中华全国总工会发布关于表彰全国模范职工之家、全国模范职工小家、全国优秀工会工作者的决定，石家庄以岭药业股份有限公司工会委员会和北京以岭药业有限公司工会委员会均获“全国模范职工之家”称号。为满足职工的休闲娱乐需求，以岭药业高标准建立面积2500平方米的“职工之家”，一、二层是职工食堂，安排免费工作餐，食堂严格管理，合理膳食搭配，营养均衡。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2024101700010442.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002603","BK0239","BK0042","BK0188","BK0097","BK0046"],"gpt_icon":0},{"id":"2474219727","title":"10月9日以岭药业跌8.53%，汇添富中证中药ETF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2474219727","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474219727?lang=zh_cn&edition=full","pubTime":"2024-10-09 17:24","pubTimestamp":1728465880,"startTime":"0","endTime":"0","summary":"证券之星消息，10月9日以岭药业跌8.53%，收盘报17.26元，换手率2.85%，成交量39.2万手，成交额6.98亿元。根据2024基金半年报公募基金重仓股数据，重仓该股的公募基金共5家，其中持有数量最多的公募基金为汇添富中证中药ETF。汇添富中证中药ETF目前规模为18.5亿元，最新净值1.2168，较上一交易日上涨4.4%，近一年上涨0.63%。汇添富中证中药ETF的前十大重仓股如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024100900031280.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159647","BK0239","BK0046","BK0188","002603","BK0042","BK0097","560080"],"gpt_icon":0},{"id":"2473411099","title":"以岭药业(002603.SZ)：中药新药“连花御屏颗粒”药物临床试验申请获得受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2473411099","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473411099?lang=zh_cn&edition=full","pubTime":"2024-10-08 15:56","pubTimestamp":1728374190,"startTime":"0","endTime":"0","summary":"智通财经APP讯，以岭药业(002603.SZ)发布公告，公司全资子公司北京以岭药业有限公司于2024年9月29日收到国家药品监督管理局核准签发的《受理通知书》，涉及药物：连花御屏颗粒。据悉，连花御屏颗粒是应用络病理论指导呼吸系统疾病防治，基于玉屏风散、桂枝汤及银翘散化裁而成治疗感冒气虚证的中药新药。其拟定功能主治为：益气固卫、祛风解毒。适用于感冒气虚证，症见恶风、畏寒、鼻塞、流涕、发热、咽痛，伴倦怠、乏力、气短、懒言、自汗、面色㿠白，舌质淡，苔薄白，脉浮细或浮细弱。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1190909.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1576","03347","002603","BK1141","BK0042","BK1583","BK0239","BK0097","BK0188","BK0046"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2011-07-28","address":"河北省石家庄市裕华区高新技术产业开发区天山大街238号","stockEarnings":[{"period":"1week","weight":-0.0168},{"period":"1month","weight":-0.0264},{"period":"3month","weight":0.1201},{"period":"6month","weight":-0.0355},{"period":"1year","weight":-0.3297},{"period":"ytd","weight":-0.2504}],"companyName":"石家庄以岭药业股份有限公司","boardCode":"AI0027","perCapita":"7251股","boardName":"医药制造业","registeredCapital":"167070万元","compareEarnings":[{"period":"1week","weight":-0.0258},{"period":"1month","weight":-0.0121},{"period":"3month","weight":0.1488},{"period":"6month","weight":0.0544},{"period":"1year","weight":0.0752},{"period":"ytd","weight":0.0957}],"survey":" 石家庄以岭药业股份有限公司是一家主要致力于专利创新中药的研发、生产和销售。主要产品包括通心络胶囊、参松养心胶囊、连花清瘟胶囊、芪苈强心胶囊等。公司拥有通过GMP认证的胶囊、片剂、颗粒剂、针剂生产线,以及通过欧盟认证的化学药制剂车间。","serverTime":1732640519807,"listedPrice":34.56,"stockholders":"189795人(较上一季度减少0.95%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"以岭药业(002603)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供以岭药业(002603)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"以岭药业,002603,以岭药业股票,以岭药业股票老虎,以岭药业股票老虎国际,以岭药业行情,以岭药业股票行情,以岭药业股价,以岭药业股市,以岭药业股票价格,以岭药业股票交易,以岭药业股票购买,以岭药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"以岭药业(002603)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供以岭药业(002603)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}